STRO-001
- Generic Name
- STRO-001
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- 0D8BWL78LD
- Associated Conditions
- -
- Associated Therapies
- -
Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies
- First Posted Date
- 2018-02-07
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- Sutro Biopharma, Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT03424603
- Locations
- 🇺🇸
Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas, United States
🇺🇸Virginia Cancer Specialists, Fairfax, Virginia, United States
🇺🇸UT Southwestern Medical Center, Dallas, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath